Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global OTC Anti-nausea Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
  • 1.2.2 Liquid
  • 1.2.3 Tablet
• 1.3 Market by Sales Channel
  • 1.3.1 Global OTC Anti-nausea Drugs Market Share by Sales Channel: 2017 VS 2021 VS 2028
  • 1.3.2 Online Sales
  • 1.3.3 Offline Sales
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global OTC Anti-nausea Drugs Market Perspective (2017-2028)
• 2.2 OTC Anti-nausea Drugs Growth Trends by Region
  • 2.2.1 OTC Anti-nausea Drugs Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 OTC Anti-nausea Drugs Historic Market Size by Region (2017-2022)
  • 2.2.3 OTC Anti-nausea Drugs Forecasted Market Size by Region (2023-2028)
• 2.3 OTC Anti-nausea Drugs Market Dynamics
  • 2.3.1 OTC Anti-nausea Drugs Industry Trends
  • 2.3.2 OTC Anti-nausea Drugs Market Drivers
  • 2.3.3 OTC Anti-nausea Drugs Market Challenges
  • 2.3.4 OTC Anti-nausea Drugs Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top OTC Anti-nausea Drugs Players by Revenue
  • 3.1.1 Global Top OTC Anti-nausea Drugs Players by Revenue (2017-2022)
  • 3.1.2 Global OTC Anti-nausea Drugs Revenue Market Share by Players (2017-2022)
• 3.2 Global OTC Anti-nausea Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by OTC Anti-nausea Drugs Revenue
• 3.4 Global OTC Anti-nausea Drugs Market Concentration Ratio
  • 3.4.1 Global OTC Anti-nausea Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by OTC Anti-nausea Drugs Revenue in 2021
• 3.5 OTC Anti-nausea Drugs Key Players Head office and Area Served
• 3.6 Key Players OTC Anti-nausea Drugs Product Solution and Service
• 3.7 Date of Enter into OTC Anti-nausea Drugs Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 OTC Anti-nausea Drugs Breakdown Data by Type

• 4.1 Global OTC Anti-nausea Drugs Historic Market Size by Type (2017-2022)
• 4.2 Global OTC Anti-nausea Drugs Forecasted Market Size by Type (2023-2028)

5 OTC Anti-nausea Drugs Breakdown Data by Sales Channel

• 5.1 Global OTC Anti-nausea Drugs Historic Market Size by Sales Channel (2017-2022)
• 5.2 Global OTC Anti-nausea Drugs Forecasted Market Size by Sales Channel (2023-2028)

6 North America

• 6.1 North America OTC Anti-nausea Drugs Market Size (2017-2028)
• 6.2 North America OTC Anti-nausea Drugs Market Size by Country (2017-2022)
• 6.3 North America OTC Anti-nausea Drugs Market Size by Country (2023-2028)
• 6.4 United States
• 6.5 Canada

7 Europe

• 7.1 Europe OTC Anti-nausea Drugs Market Size (2017-2028)
• 7.2 Europe OTC Anti-nausea Drugs Market Size by Country (2017-2022)
• 7.3 Europe OTC Anti-nausea Drugs Market Size by Country (2023-2028)
• 7.4 Germany
• 7.5 France
• 7.6 U.K.
• 7.7 Italy
• 7.8 Russia
• 7.9 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific OTC Anti-nausea Drugs Market Size (2017-2028)
• 8.2 Asia-Pacific OTC Anti-nausea Drugs Market Size by Country (2017-2022)
• 8.3 Asia-Pacific OTC Anti-nausea Drugs Market Size by Country (2023-2028)
• 8.4 China
• 8.5 Japan
• 8.6 South Korea
• 8.7 Southeast Asia
• 8.8 India
• 8.9 Australia

9 Latin America

• 9.1 Latin America OTC Anti-nausea Drugs Market Size (2017-2028)
• 9.2 Latin America OTC Anti-nausea Drugs Market Size by Country (2017-2022)
• 9.3 Latin America OTC Anti-nausea Drugs Market Size by Country (2023-2028)
• 9.4 Mexico
• 9.5 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa OTC Anti-nausea Drugs Market Size (2017-2028)
• 10.2 Middle East & Africa OTC Anti-nausea Drugs Market Size by Country (2017-2022)
• 10.3 Middle East & Africa OTC Anti-nausea Drugs Market Size by Country (2023-2028)
• 10.4 Turkey
• 10.5 Saudi Arabia
• 10.6 UAE

11 Key Players Profiles

• 11.1 Church & Dwight
  • 11.1.1 Church & Dwight Company Detail
  • 11.1.2 Church & Dwight Business Overview
  • 11.1.3 Church & Dwight OTC Anti-nausea Drugs Introduction
  • 11.1.4 Church & Dwight Revenue in OTC Anti-nausea Drugs Business (2017-2022)
  • 11.1.5 Church & Dwight Recent Development
• 11.2 Prestige Consumer Healthcare
  • 11.2.1 Prestige Consumer Healthcare Company Detail
  • 11.2.2 Prestige Consumer Healthcare Business Overview
  • 11.2.3 Prestige Consumer Healthcare OTC Anti-nausea Drugs Introduction
  • 11.2.4 Prestige Consumer Healthcare Revenue in OTC Anti-nausea Drugs Business (2017-2022)
  • 11.2.5 Prestige Consumer Healthcare Recent Development
• 11.3 Procter & Gamble
  • 11.3.1 Procter & Gamble Company Detail
  • 11.3.2 Procter & Gamble Business Overview
  • 11.3.3 Procter & Gamble OTC Anti-nausea Drugs Introduction
  • 11.3.4 Procter & Gamble Revenue in OTC Anti-nausea Drugs Business (2017-2022)
  • 11.3.5 Procter & Gamble Recent Development
• 11.4 Kramer Laboratories
  • 11.4.1 Kramer Laboratories Company Detail
  • 11.4.2 Kramer Laboratories Business Overview
  • 11.4.3 Kramer Laboratories OTC Anti-nausea Drugs Introduction
  • 11.4.4 Kramer Laboratories Revenue in OTC Anti-nausea Drugs Business (2017-2022)
  • 11.4.5 Kramer Laboratories Recent Development
• 11.5 WellSpring Pharmaceutical Corporation
  • 11.5.1 WellSpring Pharmaceutical Corporation Company Detail
  • 11.5.2 WellSpring Pharmaceutical Corporation Business Overview
  • 11.5.3 WellSpring Pharmaceutical Corporation OTC Anti-nausea Drugs Introduction
  • 11.5.4 WellSpring Pharmaceutical Corporation Revenue in OTC Anti-nausea Drugs Business (2017-2022)
  • 11.5.5 WellSpring Pharmaceutical Corporation Recent Development
• 11.6 Alva-Amco
  • 11.6.1 Alva-Amco Company Detail
  • 11.6.2 Alva-Amco Business Overview
  • 11.6.3 Alva-Amco OTC Anti-nausea Drugs Introduction
  • 11.6.4 Alva-Amco Revenue in OTC Anti-nausea Drugs Business (2017-2022)
  • 11.6.5 Alva-Amco Recent Development
• 11.7 Boiron
  • 11.7.1 Boiron Company Detail
  • 11.7.2 Boiron Business Overview
  • 11.7.3 Boiron OTC Anti-nausea Drugs Introduction
  • 11.7.4 Boiron Revenue in OTC Anti-nausea Drugs Business (2017-2022)
  • 11.7.5 Boiron Recent Development
• 11.8 Guangzhou Baiyunshan Pharmaceutical
  • 11.8.1 Guangzhou Baiyunshan Pharmaceutical Company Detail
  • 11.8.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
  • 11.8.3 Guangzhou Baiyunshan Pharmaceutical OTC Anti-nausea Drugs Introduction
  • 11.8.4 Guangzhou Baiyunshan Pharmaceutical Revenue in OTC Anti-nausea Drugs Business (2017-2022)
  • 11.8.5 Guangzhou Baiyunshan Pharmaceutical Recent Development
• 11.9 Taisho Pharmaceutical
  • 11.9.1 Taisho Pharmaceutical Company Detail
  • 11.9.2 Taisho Pharmaceutical Business Overview
  • 11.9.3 Taisho Pharmaceutical OTC Anti-nausea Drugs Introduction
  • 11.9.4 Taisho Pharmaceutical Revenue in OTC Anti-nausea Drugs Business (2017-2022)
  • 11.9.5 Taisho Pharmaceutical Recent Development
• 11.10 SSP CO.
  • 11.10.1 SSP CO. Company Detail
  • 11.10.2 SSP CO. Business Overview
  • 11.10.3 SSP CO. OTC Anti-nausea Drugs Introduction
  • 11.10.4 SSP CO. Revenue in OTC Anti-nausea Drugs Business (2017-2022)
  • 11.10.5 SSP CO. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Summary:

Industry Insights
The global OTC Anti-nausea Drugs market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Liquid accounting for % of the OTC Anti-nausea Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Online Sales segment is altered to an % CAGR throughout this forecast period.
China OTC Anti-nausea Drugs market size is valued at US$ million in 2021, while the North America and Europe OTC Anti-nausea Drugs are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe OTC Anti-nausea Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global OTC Anti-nausea Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global OTC Anti-nausea Drugs market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global OTC Anti-nausea Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global OTC Anti-nausea Drugs market.
Impact of Covid-19 Outbreak
This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.
Segmental Analysis
The report has been segmented into product and application segments. The researchers have documented all the products present today in the OTC Anti-nausea Drugs market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.
OTC Anti-nausea Drugs Breakdown Data by Type
Liquid
Tablet
OTC Anti-nausea Drugs Breakdown Data by Sales Channel
Online Sales
Offline Sales
Regional Analysis
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape
This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:
Church & Dwight
Prestige Consumer Healthcare
Procter & Gamble
Kramer Laboratories
WellSpring Pharmaceutical Corporation
Alva-Amco
Boiron
Guangzhou Baiyunshan Pharmaceutical
Taisho Pharmaceutical
SSP CO.
Frequently Asked Questions
What factors will challenge the OTC Anti-nausea Drugs market growth?
Which end-use segment will expand at the fastest CAGR in the OTC Anti-nausea Drugs market?
Which are the emerging players in the OTC Anti-nausea Drugs market?
How concentrated is the OTC Anti-nausea Drugs market?
Which factors are positively contributing to the OTC Anti-nausea Drugs market growth?
Which are the novel product innovations in the OTC Anti-nausea Drugs market?
Which product segment will emerge as the most lucrative in the OTC Anti-nausea Drugs market?
Which factors are increasing the competition in the OTC Anti-nausea Drugs market?
Which are the strategic measures taken by the OTC Anti-nausea Drugs industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the OTC Anti-nausea Drugs market in the coming years?